BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company), and Diagenode SA, an international biotech company based in Belgium, have announced the availability of the CE-marked Diagenode Enteric Viral Panel primers and probes kit that is used with the BD MAX RNA extraction kit RNA3 and BD MAX PCR Cartridges. BD has also announced the availability of the CE-marked BD MAX Enteric Bacterial Panel for use on the BD MAX System.
Company representatives stress that these new products available on the BD MAX System provide a fully automated system that standardizes the extraction process and offers ease-of-use and improved laboratory workflow. In addition to panels detecting enteric viral and bacterial pathogens, a BD MAX Enteric Ovum and Parasite Panel is currently in development for the qualitative detection of parasitic enteric pathogens Giardia lamblia, Cryptosporidium spp. (C. hominus and C. parvum), and Entamoeba histolytica directly from stool specimens in patients with signs and symptoms of gastroenteritis and/or colitis.
The Diagenode Enteric Viral Panel primers and probes kit is an automated in vitro diagnostic (IVD) test for the qualitative detection of norovirus (genogroups I and II) and rotavirus species in stool specimens. The BD MAX Enteric Bacterial Panel is a qualitative IVD test detecting DNA from Campylobacter spp. (jejuni and coli), Salmonella spp., Shigellosis disease (Shigella spp./Enteroinvasive E. coli [EIEC]) as well as Shiga-toxin Types 1a and 2a.
BD plans to continue expanding the BD MAX molecular testing menu through internal development and the Diagenode collaboration by launching additional assays throughout 2013. Learn more about diagnostics systems offered by BD.
